Methylation-induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1

EMBO Journal

Volumn 22, Issue 9, 2003, Pages 2245-2254

  Cejka, Petr ^a   Stojic, Lovorka ^a   Mojas, Nina ^a   Russell, Anna Marie ^b   Heinimann, Karl ^b   Cannavó, Elda ^a   Di Pietro, Massimiliano ^a   Marra, Giancarlo ^a   Jiricny, Josef ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cell cycle checkpoint; hMLH1; Methylating agent; Mismatch repair; TetOff

Indexed keywords

DOXYCYCLINE; METHYLNITRONITROSOGUANIDINE; POLYPEPTIDE; PROTEIN MLH1; PROTEIN P53; VIRUS LARGE T ANTIGEN;

ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EMBRYO; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; METAPHASE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MITOSIS INHIBITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALKYLATING AGENTS; BASE PAIR MISMATCH; CARRIER PROTEINS; CELL LINE; DNA METHYLATION; DNA REPAIR; G2 PHASE; HUMANS; METHYLNITRONITROSOGUANIDINE; MITOSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS;

EID: 0037881803     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg216     Document Type: Article

References (39)

1. Adamson, A.W., Kim, W.J., Shangary, S., Baskaran, R. and Brown, K.D. (2002) ATM is activated in response to N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA alkylation. J. Biol. Chem., 277, 38222-38229.
2. Bellacosa, A. (2001) Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ., 8, 1076-1092.
3. Boyer, J.C., Umar, A., Risinger, J.I., Lipford, J.R., Kane, M., Yin, S., Barrett, J.C., Kolodner, R.D. and Kunkel, T.A. (1995) Microsatellite instability, mismatch repair deficiency and genetic defects in human cancer cell lines. Cancer Res., 55, 6063-6070.
4. Buermeyer, A.B., Wilson-Van Patten, C., Baker, S.M. and Liskay, R.M. (1999) The human MLH1 cDNA complements DNA mismatch repair defects in Mlh1-deficient mouse embryonic fibroblasts. Cancer Res., 59, 538-541.
5. Claij, N. and Te Riele, H. (2002) Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level. Oncogene, 21, 2873-2879.
6. de Wind, N., Dekker, M., Berns, A., Radman, M. and te Riele, H. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell, 82, 321-330.
7. de Wind, N., Dekker, M., van Rossum, A., van der Valk, M. and te Riele, H. (1998) Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res., 58, 248-255.
8. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl Acad. Sci. USA, 93, 6443-6447.
9. Duckett, D.R., Bronstein, S.M., Taya, Y. and Modrich, P. (1999) hMutSα-and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl Acad. Sci. USA, 96, 12384-12388.
10. Esteller, M. (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21, 5427-5440.
11. Fishel, R. (1999) Signaling mismatch repair in cancer. Nat. Med., 5, 1239-1241.
12. Harfe, B.D. and Jinks-Robertson, S. (2000) DNA mismatch repair and genetic instability. Annu. Rev. Genet., 34, 359-399.
13. Hickman, M.J. and Samson, L.D. (1999) Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl Acad. Sci. USA, 96, 10764-10769.
14. Holmes, J.J., Clark, S. and Modrich, P. (1990) Strand-specific mismatch correction in nuclear extracts of human and Drosophila melanogaster cell lines. Proc. Natl Acad. Sci. USA, 87, 5837-5841.
15. 6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models. Mutat. Res., 381, 227-241.
16. Karran, P., and Bignami, M. (1996) Drug-related killings: a case of mistaken identity. Chem. Biol., 3, 875-879.
17. Kinzler, K.W. and Vogelstein, B. (1998) Landscaping the cancer terrain. Science, 280, 1036-1037.
18. Kleczkowska, H.E., Marra, G., Lettieri, T. and Jiricny, J. (2001) hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci. Genes Dev., 15, 724-736.
19. Koi, M., Umar, A., Chauhan, D.P., Cherian, S.P., Carethers, J.M., Kunkel, T.A. and Boland, C.R. (1994) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation (published erratum appears in Cancer Res., 1995, 55, 201). Cancer Res., 54, 4308-4312.
20. Lettieri, T., Marra, G., Aquilina, G., Bignami, M., Crompton, N.E., Palombo, F. and Jiricny, J. (1999) Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis, 20, 373-382.
21. Loeb, L.A. (1985) Apurinic sites as mutagenic intermediates. Cell, 40, 483-484.
22. Loukola, A., Eklin, K., Laiho, P., Salovaara, R., Kristo, P., Jarvinen, H., Mecklin, J.P., Launonen, V. and Aaltonen, L.A. (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res., 61, 4545-4549.
23. Markowitz, S.D., Dawson, D.M., Willis, J. and Willson, J.K. (2002) Focus on colon cancer. Cancer Cell, 1, 233-236.
24. Marra, G. et al. (2001) Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Proc. Natl Acad. Sci. USA, 98, 7164-7169.
25. Nystrom-Lahti, M. et al. (2002) Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer, 33, 160-167.
26. Osborn, A.J., Elledge, S.J. and Zou, L. (2002) Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol., 12, 509-516.
27. Paull, T.T., Rogakou, E.P., Yamazaki, V., Kirchgessner, C.U., Gellert, M. and Bonner, W.M. (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol., 10, 886-895.
28. Peltomaki, P. (2001) DNA mismatch repair and cancer. Mutat. Res., 488, 77-85.
29. Räschle, M., Marra, G., Nyström-Lahti, M., Schär, P. and Jiricny, J. (1999) Identification of hMutLβ, a Heterodimer of hMLH1 and hPMS1. J. Biol. Chem., 274, 32368-32375.
30. Redon, C., Pilch, D., Rogakou, E., Sedelnikova, O., Newrock, K. and Bonner, W. (2002) Histone H2A variants H2AX and H2AZ. Curr. Opin. Genet. Dev., 12, 162-169.
31. Risinger, J.I., Umar, A., Glaab, W.E., Tindall, K.R., Kunkel, T.A. and Barrett, J.C. (1998) Single gene complementation of the hPMS2 defect in HEC-I-A endometrial carcinoma cells. Cancer Res., 58, 2978-2981.
32. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Shcherbakova, P.V. and Kunkel, T.A. (1999) Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol. Cell. Biol., 19, 3177-3183.
34. Shcherbakova, P.V., Hall, M.C., Lewis, M.S., Bennett, S.E., Martin, K.J., Bushel, P.R., Afshari, C.A. and Kunkel, T.A. (2001) Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol. Cell. Biol., 21, 940-951.
35. Shin, K.H., Han, H.J. and Park, J.G. (1998) Growth suppression mediated by transfection of wild-type hMLH1 in human cancer cells expressing endogenous truncated hMLH1 protein. Int. J. Oncol., 12, 609-615.
36. Thomas, D.C., Roberts, J.D. and Kunkel, T.A. (1991) Heteroduplex repair in extracts of human HeLa cells. J. Biol. Chem., 266, 3744-3751.
37. Tibbetts, R.S., Brumbaugh, K.M., Williams, J.M., Sarkaria, J.N., Cliby, W.A., Shieh, S.Y., Taya, Y., Prives, C. and Abraham, R.T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev., 13, 152-157.
38. Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J. and Marra, G. (2002) Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology, 122, 211-219.
39. Zhang, H., Richards, B., Wilson, T., Lloyd, M., Cranston, A., Thorburn, A., Fishel, R. and Meuth, M. (1999) Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res., 59, 3021-3027.